![]() |
|
![]() As one of the world’s leading, specialty pharmaceutical companies, Biovail Corporation has a strong commitment to corporate governance. The Company steadfastly believes that strong corporate-governance practices provide shareholders with the assurance they require that Biovail is being operated in their best interests. To this end, Biovail and its Board of Directors, under the leadership of Board Chairman, Dr. Douglas Squires, is committed to building and maintaining a proactive governance culture that seeks to continuously improve and incorporate the highest standards of ethical behavior throughout all aspects of the business. The links that follow provide more information on Biovail’s current practices and procedures related to corporate governance at the Company. Additional information - including financial reports and links to Biovail’s regulatory filings on the System for Electronic Document Analysis and Retrieval (SEDAR) and Electronic Document Analysis and Retrieval (EDGAR), can be located on biovail.com, under Investor Relations. Board of Directors
Governance Documents
Director Position Descriptions
Board Committee Charters
Non-Board Committee Charters
Other
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| © 2007 Biovail Corporation - All Rights Reserved (BIO113B0602) | Privacy Policy | Disclaimers |